atrial fibrillation
Conditions
Interventions
1:Vitamin C Intravenous Administration During the Perioperative Period
Sponsors
Chinese Academy of Medical Sciences Fuwai Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. 18 years old<=age<=75 years; 2. Atrial fibrillation ablation surgery for the first time; 3. Atrial fibrillation ablation surgery has been completed for at least 3 months; 4. Follow-up has been completed.
Exclusion criteria
Exclusion criteria: 1. Previous atrial fibrillation catheter ablation or surgical treatment; 2. Severely enlarged left atrium (echocardiography >55mm) or left ventricular ejection fraction < 30%; 3. Estimated glomerular filtration rate < 30 mL·min?¹·1.73 m?² or history of kidney stones; 4. Known history of glucose-6-phosphate dehydrogenase deficiency or hemochromatosis; 5. Active malignancy or life expectancy < 1 year; 6. Pregnancy or lactation; 7. Participation in another interventional clinical trial; 8. There is a lack of clinical data and the inability to collect relevant medical records.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| AF, atrial flutter, or atrial tachycardia >30 s on ECG or 24 hours Holters; | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart failure rehospitalization;Permanent pacemaker implantation;Stroke or cerebral hemorrhage;All-cause death; | — |
Countries
China
Contacts
Public ContactYuhe Jia
Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College
Outcome results
None listed